Scotland approves take at home MS drug in UK first
The Scottish Medicines Consortium (SMC) has approved a new treatment for patients with multiple sclerosis (MS), the first country in the UK to do so.
Scottish medicines consortium
Latest news
- 26 February, 2021 | Rare Disease Day: Rare is stronger with community
- 25 February, 2021 | Tamzin Outhwaite supports disability charity’s appeal to help raise £2m over the next two years
- 25 February, 2021 | VACCINE: Sharing positive experiences and stressing the importance of prioritisation for people with a learning disability
- 24 February, 2021 | Decision made to call people with learning disabilities for the COVID-19 vaccination in priority group six
- 19 February, 2021 | Interview: Normalising arthritis in young people